Search Results - Ofierska-Sujkowska, G

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Correlation Between Hospitalized Morbidity and Cost of Treatment of Selected Chronic Diseases

    Correlation Between Hospitalized Morbidity and Cost of Treatment of Selected Chronic Diseases by Ofierska-Sujkowska, G, Jagodzinska-Kalinowska, K, Matusewicz, W

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The influence of recommendations related to cardiovascular drugs issued by agency for health technology assessment in poland (aotm) in years 2005-2012 for the reimbursement decisions

    The influence of recommendations related to cardiovascular drugs issued by agency for health technology assessment in poland (aotm) in years 2005-2012 for the reimbursement decisio... by Ofierska-Sujkowska, G, Jagodzinska-Kalinowska, K, Matusewicz, W

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The Cost-Effectiveness Threshold For Orphan Designations in Poland Based on Reimbursement Decisions

    The Cost-Effectiveness Threshold For Orphan Designations in Poland Based on Reimbursement Decisions by Grzywacz, K, Pelczarska, A, Witkowski, M.A, Ofierska-Sujkowska, G, Zawada, A

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    PHP56 The Role of Antineoplastic and Immunomodulating Agents in Works and Recommendations of Agency for Health Technology Assessment in Poland (AOTM) in Years 2005-2011

    PHP56 The Role of Antineoplastic and Immunomodulating Agents in Works and Recommendations of Agency for Health Technology Assessment in Poland (AOTM) in Years 2005-2011 by Ofierska-Sujkowska, G, Matusewicz, W, Jagodzinska-Kalinowska, K

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PCV112 The Focus on Cardiovascular Drugs in Works of Agency for Health Technology Assessment in Poland (AOTM) in Years 2005-2011 As an Example of a Light Touch HTA Agency

    PCV112 The Focus on Cardiovascular Drugs in Works of Agency for Health Technology Assessment in Poland (AOTM) in Years 2005-2011 As an Example of a Light Touch HTA Agency by Ofierska-Sujkowska, G, Jagodzinska-Kalinowska, K, Matusewicz, W, Pasierski, T

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    PHP74 Low Efficacy of Innovative Drugs as a Key Factor of Negative Recommendations Issued by Agency for Health Technology Assessment in Poland (AOTM) in 2011

    PHP74 Low Efficacy of Innovative Drugs as a Key Factor of Negative Recommendations Issued by Agency for Health Technology Assessment in Poland (AOTM) in 2011 by Ofierska-Sujkowska, G, Jagodzinska-Kalinowska, K, Matusewicz, W, Pasierski, T

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    PHP55 THE INFLUENCE OF COST-EFFECTIVENESS ISSUES OF THE APPRAISED ORPHAN DRUGS ON RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL)

    PHP55 THE INFLUENCE OF COST-EFFECTIVENESS ISSUES OF THE APPRAISED ORPHAN DRUGS ON RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL) by Ofierska-Sujkowska, G, Jagodzinska-Kalinowska, K, Matusewicz, W

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

    Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers by Adamski, Jakub, Godman, Brian, Ofierska-Sujkowska, Gabriella, Osińska, Bogusława, Herholz, Harald, Wendykowska, Kamila, Laius, Ott, Jan, Saira, Sermet, Catherine, Zara, Corrine, Kalaba, Marija, Gustafsson, Roland, Garuolienè, Kristina, Haycox, Alan, Garattini, Silvio, Gustafsson, Lars L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology Drugs

    PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology Drugs by Ofierska-Sujkowska, G, Jagodzinska-Kalinowska, K, Matusewicz, W, Pasierski, T

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    PHP100 - Correlation Between Hospitalized Morbidity and Cost of Treatment of Selected Chronic Diseases

    PHP100 - Correlation Between Hospitalized Morbidity and Cost of Treatment of Selected Chronic Diseases by Ofierska-Sujkowska, G., Jagodzinska-Kalinowska, K., Matusewicz, W.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    PCV138 - The influence of recommendations related to cardiovascular drugs issued by agency for health technology assessment in poland (aotm) in years 2005-2012 for the reimbursement decisions

    PCV138 - The influence of recommendations related to cardiovascular drugs issued by agency for health technology assessment in poland (aotm) in years 2005-2012 for the reimbursemen... by Ofierska-Sujkowska, G., Jagodzinska-Kalinowska, K., Matusewicz, W.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    PHP277 - The Cost-Effectiveness Threshold For Orphan Designations in Poland Based on Reimbursement Decisions

    PHP277 - The Cost-Effectiveness Threshold For Orphan Designations in Poland Based on Reimbursement Decisions by Grzywacz, K., Pelczarska, A., Witkowski, M.A., Ofierska-Sujkowska, G., Zawada, A.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: